Compare
2 stocks, side by sideRelative performance · rebased to 100
ASNDBBIO
Pair ratio · ASND ÷ BBIORelative value, rich or cheap vs their own history
The price ratio ASND ÷ BBIO with its 1Y mean and ±1σ / ±2σ bands; the z-score is how far the ratio sits from its average. A stretched reading flags one stock as rich vs the other relative to their history, but mean-reversion isn't guaranteed (a durable re-rating from better growth or margins can keep the ratio elevated). Research tooling, not advice.
| ASNDAscendis Pharma A/S | BBIOBridgeBio Pharma, Inc. | |
|---|---|---|
| Smart Score | 8/10 | 3/10 |
| Price | $261.58 | $69.69 |
| 1 month | +9.2% | +2.9% |
| 1 year | +46% | +57% |
| 5 year | +90% | +11% |
| P/E (TTM) | 34.6 | -18.9 |
| P/E vs sector | +10% | - |
| Market cap | $17.2B | $13.6B |
| Sector | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.